End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.38 USD | -9.38% | -10.34% | -27.62% |
06-14 | Zura Bio Presents Data for the Tibulizumab (Zb-106) Program At Eular 2024 | CI |
06-06 | Zura Bio Limited Announces Formation of a Scientific Advisory Board | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.62% | 213M | |
+15.19% | 121B | |
+19.91% | 114B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B | |
+119.39% | 10.96B |
- Stock Market
- Equities
- ZURA Stock
- News Zura Bio Limited
- Piper Sandler Starts Zura Bio With Overweight Rating, $26 Price Target